Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure

European Journal of Heart Failure

Volumn 13, Issue 2, 2011, Pages 220-226

  De Peuter, Olav R ^a   Souverein, Patrick C ^b   Klungel, Olaf H ^b   Bller, Harry R ^a   De Boer, Anthonius ^b   Kamphuisen, Pieter W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Beta blockers; Epidemiology; Heart failure; Pharmacology; Thromboembolism

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CARVEDILOL; CELIPROLOL; FUROSEMIDE; LABETALOL; METOPROLOL; NEBIVOLOL; OXPRENOLOL; PINDOLOL; PROPRANOLOL; SOTALOL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; STROKE; THROMBOEMBOLISM;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; THROMBOEMBOLISM;

EID: 79551492821     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq176     Document Type: Article

References (24)

1. Chung I, Lip GY. Antithrombotic therapy for congestive heart failure. Int J Clin Pract 2006;60:36-47.
2. Chung I, Lip GY. Platelets and heart failure. Eur Heart J 2006;27:2623-2631.
3. De Peuter OR, Kok WE, Torp-Pedersen C, Buller HR, Kamphuisen PW. Systolic heart failure: a prothrombotic state. Semin Thromb Hemost 2009;35:497-504.
4. Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999;33:1424-1426.
5. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001;103:1746-1751.
6. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JG. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994;127:607-612.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
8. Von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000;65:357-369.
9. Grignani G, Pacchiarini L, Zucchella M, Tacconi F, Canevari A, Soffiantino F, Tavazzi L. Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease. Haemostasis 1992;22:138-146.
10. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. The Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004;25:1341-1362.
11. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD. Nonselective vs. selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001;104:2194-2199.
12. Kohno T, Yoshikawa T, Yoshizawa A, Nakamura I, Anzai T, Satoh T, Ogawa S. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure. Cardiovasc Drugs Ther 2005;19:347-355.
13. Hoppener MR, Kraaijenhagen RA, Hutten BA, Buller HR, Peters RJ, Levi M. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. J Thromb Haemost 2004;2:1316-1320.
14. De Peuter OR, Lussana F, Peters RJ, Buller HR, Kamphuisen PW. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. Neth J Med 2009;67:284-294.
15. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-1112.
16. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006;97:1759-1764.
17. Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, Sorensen R, Folke F, Gadsboll N, Rasmussen S, Kober L, Madsen M, Torp-Pedersen C. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation 2007;116:737-744.
18. Van Wieren-de Wijer DB, Maitland-van der Zee AH, De Boer A, Kroon AA, De Leeuw PW, Schiffers P, Janssen RG, Psaty BM, Van Duijn CM, Stricker BH, Klungel OH. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J Hypertens 2009;27:61-68.
19. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Ryden L. Mode of death in heart failure: findings from the ATLAS trial. Heart 2003;89: 42-48.
20. Kober L, Torp-Pedersen C, Calsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-1676.
21. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340: 1173-1178.
22. Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di LA, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure-COMET. Am Heart J 2005;149:370-376.
23. Doggrell SA. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure? Expert Opin Pharmacother 2004;5: 205-208.
24. Roy D, Talajic M, Dubuc M, Thibault B, Guerra P, Macle L, Khairy P. Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 2009;24:29-34.